Vanda Pharmaceuticals Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Vanda Pharmaceuticals Inc 公司

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Vanda Pharmaceuticals Inc簡介



公司代碼VNDA

公司名稱Vanda Pharmaceuticals Inc

上市日期Apr 12, 2006

CEOPolymeropoulos (Mihael Hristos)

員工數量368

證券類型Ordinary Share

年結日Apr 12

公司地址Suite 300E

城市WASHINGTON

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編20037

電話12027343400

網址https://www.vandapharma.com/

公司代碼VNDA

上市日期Apr 12, 2006

CEOPolymeropoulos (Mihael Hristos)

Vanda Pharmaceuticals Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Mihael Hristos Polymeropoulos, M.D.

Chairman of the Board, President, Chief Executive Officer

2.34M

+10000.00%

Mr. Gunther Birznieks

Senior Vice President - Business Development

411.63K

+174050.00%

Mr. Kevin Patrick Moran

Chief Financial Officer, Senior Vice President, Treasurer

329.46K

+178386.00%

Mr. Richard W. Dugan

Lead Independent Director

177.45K

+59225.00%

Dr. Tage Honore, Ph.D.

Independent Director

123.47K

+59225.00%

Ms. Anne Sempowski Ward

Independent Director

119.07K

+59225.00%

Dr. Stephen Ray Mitchell, M.D.

Independent Director

97.08K

+52225.00%

Mr. Timothy I. Williams

Senior Vice President, General Counsel, Secretary

--

Ms. Phaedra S. Chrousos

Independent Director

--

Mr. Joakim (Kim) Wijkstrom

Senior Vice President, Chief Marketing Officer

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Mihael Hristos Polymeropoulos, M.D.

Chairman of the Board, President, Chief Executive Officer

2.34M

+10000.00%

Mr. Gunther Birznieks

Senior Vice President - Business Development

411.63K

+174050.00%

Mr. Kevin Patrick Moran

Chief Financial Officer, Senior Vice President, Treasurer

329.46K

+178386.00%

Mr. Richard W. Dugan

Lead Independent Director

177.45K

+59225.00%

Dr. Tage Honore, Ph.D.

Independent Director

123.47K

+59225.00%

Ms. Anne Sempowski Ward

Independent Director

119.07K

+59225.00%

收入明細

單位: USD更新時間: 1月6日週二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Fanapt

31.25M

55.54%

Hetlioz

17.98M

31.96%

PONVORY

7.04M

12.50%

由於公司未披露，未能獲取相關數據

業務

地區

業務USD

名稱

營收

佔比

Fanapt

31.25M

55.54%

Hetlioz

17.98M

31.96%

PONVORY

7.04M

12.50%

股東統計

更新時間: 2月4日週三

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

9.77%

The Vanguard Group, Inc.

6.26%

Renaissance Technologies LLC

5.88%

Dimensional Fund Advisors, L.P.

4.34%

Tang Capital Management, LLC

3.98%

其他

69.76%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

9.77%

The Vanguard Group, Inc.

6.26%

Renaissance Technologies LLC

5.88%

Dimensional Fund Advisors, L.P.

4.34%

Tang Capital Management, LLC

3.98%

其他

69.76%

股東類型

持股股東

佔比

Investment Advisor

28.50%

Investment Advisor/Hedge Fund

26.41%

Hedge Fund

17.28%

Individual Investor

7.19%

Private Equity

2.47%

Research Firm

1.71%

Pension Fund

0.27%

Bank and Trust

0.20%

Sovereign Wealth Fund

0.19%

其他

15.76%

機構持股



更新時間: 1月1日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

346

45.82M

77.53%

-10.46M

2025Q3

373

46.45M

78.60%

-9.99M

2025Q2

417

50.75M

85.90%

-11.31M

2025Q1

426

48.51M

82.37%

-12.27M

2024Q4

444

46.48M

79.71%

-15.23M

2024Q3

446

47.42M

81.36%

-14.93M

2024Q2

445

46.99M

80.73%

-18.42M

2024Q1

434

53.50M

92.97%

-11.41M

2023Q4

445

55.38M

96.27%

-9.21M

2023Q3

446

56.79M

98.75%

-12.15M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.77M

9.77%

-211.76K

-3.54%

Sep 30, 2025

The Vanguard Group, Inc.

3.56M

6.02%

+14.34K

+0.40%

Sep 30, 2025

Renaissance Technologies LLC

3.48M

5.88%

+29.46K

+0.85%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

2.56M

4.34%

-21.79K

-0.84%

Sep 30, 2025

Tang Capital Management, LLC

2.35M

3.98%

--

Sep 30, 2025

Polymeropoulos (Mihael Hristos)

2.34M

3.95%

+10.00K

+0.43%

Aug 07, 2025

BlackRock Financial Management, Inc.

2.25M

3.8%

-186.40K

-7.66%

Sep 30, 2025

Acadian Asset Management LLC

2.23M

3.77%

+496.85K

+28.69%

Sep 30, 2025

Millennium Management LLC

3.25M

5.5%

+130.50K

+4.18%

Sep 30, 2025

Two Sigma Investments, LP

1.57M

2.66%

+235.54K

+17.63%

Sep 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

iShares Neuroscience and Healthcare ETF

0.49%

Invesco NASDAQ Future Gen 200 ETF

0.49%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.12%

ALPS Medical Breakthroughs ETF

0.1%

Federated Hermes MDT Small Cap Core ETF

0.09%

iShares Micro-Cap ETF

0.05%

ProShares Ultra Nasdaq Biotechnology

0.04%

Franklin US Small Cap Multifactor Index ETF

0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.04%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.03%

iShares Neuroscience and Healthcare ETF

佔比0.49%

Invesco NASDAQ Future Gen 200 ETF

佔比0.49%

SPDR SSGA US Small Cap Low Volatility Index ETF

佔比0.12%

ALPS Medical Breakthroughs ETF

佔比0.1%

Federated Hermes MDT Small Cap Core ETF

佔比0.09%

iShares Micro-Cap ETF

佔比0.05%

ProShares Ultra Nasdaq Biotechnology

佔比0.04%

Franklin US Small Cap Multifactor Index ETF

佔比0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.04%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

佔比0.03%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據